Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Cardinal Health, Inc.    CAH

CARDINAL HEALTH, INC.

(CAH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Cardinal Health : Sheri Edison to join Cardinal Health Board of Directors

share with twitter share with LinkedIn share with facebook
09/25/2020 | 05:45am EDT

DUBLIN, Ohio, Aug. 31, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its board of directors has elected Sheri Edison as an independent director, effective September 1. Ms. Edison joins the board with extensive experience as a senior legal executive in the medical device and packaging industries.

Ms. Edison currently serves as Executive Vice President and General Counsel for Amcor plc, a global leader in packaging for products spanning the food, beverage, pharmaceutical, medical, home and personal care sectors, with approximately 50,000 employees across more than 40 countries. She previously held the role of Senior Vice President, Chief Legal Officer and Secretary for Bemis Company, Inc. until it was acquired by Amcor, as well as Senior Vice President, Chief Administrative Officer of the medical device company Hill-Rom Holdings, Inc. Prior to these positions, Ms. Edison also served in multiple senior legal roles at other leading companies and as an attorney in private practice.

Currently, Ms. Edison serves on the board of directors for American Family Insurance and on the Board of Visitors of the University of Wisconsin Waisman Center. She also formerly served on the Board of Directors of AK Steel where she chaired the Nominating and Corporate Governance Committee.

'We are very pleased to welcome Sheri as a director,' said Gregory Kenny, Chairman of the Board for Cardinal Health. 'Sheri brings both strong leadership experience across areas of legal and regulatory compliance and corporate governance as well as a healthcare industry background that complement the experiences and skillsets of our current directors. She has led a number of critical business functions and initiatives, including IT and strategic planning efforts during her career, and we look forward to benefitting from her deep expertise and knowledge of complex businesses.'

Ms. Edison holds a Juris Doctor from Northwestern University School of Law and a Bachelor of Arts in History and Journalism from University of Southern California.

About Cardinal Health
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company enhances supply chain efficiency for clinically proven medical products, pharmaceuticals and cost-effective solutions. To combat prescription drug misuse, the Cardinal Health Foundation and its education partners created Generation Rx, a national drug prevention education and awareness program. The Foundation actively supports an array of other solutions, including efforts to reduce opioid prescribing, promote drug take back and safe disposal and expand collaborative community work.

Cardinal Health is backed by nearly 100 years of experience with operations in nearly 46 countries. For more information, visit cardinalhealth.com. Follow us on Twitter, Facebook and LinkedIn.

Contacts
Media: Sarah Shew, sarah.shew@cardinalhealth.com and 614.553.3401
Investors: Kevin Moran, kevin.moran@cardinalhealth.com and 614.757.7942.

View original content to download multimedia:http://www.prnewswire.com/news-releases/sheri-edison-to-join-cardinal-health-board-of-directors-301121180.html

SOURCE Cardinal Health

Disclaimer

Cardinal Health Inc. published this content on 31 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 September 2020 08:44:01 UTC


share with twitter share with LinkedIn share with facebook
All news about CARDINAL HEALTH, INC.
10/28Combined Market Cap of Five Largest MedTech Companies Surged by $40bn YoY
AQ
10/22Walmart Files Pre-emptive Lawsuit Against Federal Government in Opioid Case
DJ
10/22Walmart Files Pre-emptive Lawsuit Against Federal Government in Opioid Case -..
DJ
10/19CARDINAL HEALTH : Upsher-Smith's Brad Leonard and Amy Dearborn Honored by Cardin..
AQ
10/13J&J to contribute up to $5 billion to potential U.S. opioid settlement
RE
10/01All Remdesivir Supplies to Be Distributed in U.S. by Maker Gilead Sciences --..
DJ
10/01All Remdesivir Supplies to Be Distributed in U.S. by Maker Gilead Sciences
DJ
09/30CARDINAL HEALTH, INC. : Ex-dividend day for
FA
09/25CARDINAL HEALTH : to Webcast Discussion of First-Quarter Results for Fiscal Year..
PR
09/25CARDINAL HEALTH : Sheri Edison to join Cardinal Health Board of Directors
PU
More news
Financials (USD)
Sales 2021 159 B - -
Net income 2021 1 271 M - -
Net Debt 2021 2 863 M - -
P/E ratio 2021 11,1x
Yield 2021 4,33%
Capitalization 13 382 M 13 382 M -
EV / Sales 2021 0,10x
EV / Sales 2022 0,09x
Nbr of Employees 48 000
Free-Float 89,4%
Chart CARDINAL HEALTH, INC.
Duration : Period :
Cardinal Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARDINAL HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 58,81 $
Last Close Price 45,61 $
Spread / Highest target 46,9%
Spread / Average Target 28,9%
Spread / Lowest Target 9,63%
EPS Revisions
Managers
NameTitle
Michael C. Kaufmann Chief Executive Officer & Director
Gregory B. Kenny Independent Non-Executive Chairman
Jason M. Hollar Chief Financial Officer
Brian S. Rice Chief Information Officer & Executive VP
J. Michael Losh Independent Director
Sector and Competitors